gr

OP-3633 is an effective and selective steroidal glucocorticoid receptor (GR) antagonist (IC50: 29 nM). OP-3633 shows low progesterone receptor (PR) agonism and androgen receptor (AR) antagonism. It also has an inhibition of GR transcriptional activity.

NXT629 是一种具有选择性和高效性的 PPAR-α 拮抗剂，具有抗癌活性，抑制 PPARδ，PPARγ，Erβ，GR 和 TRβ，可用于研究卵巢癌和黑色素瘤。

Exicorilant is a selective and oral active glucocorticoid receptor (GR) antagonist (Ki: 7 nM) and it also has the potential to overcome adiposity, glucose intolerance, and dyslipidemia.

GR-95168 ((+)-C-BVDU) 是一种抗病毒化合物，可用于研究1型和2型单纯疱疹病毒感染。

GR 103691 是选择性的多巴胺 D3受体拮抗剂，Ki=0.4 nM。它对人多巴胺 D3的选择性超过 D4和 D1的 100 倍以上。

GR 113808 是一种具有选择性的 5-HT4 receptor 拮抗剂，抑制 5-HT1B，5-HT2A，5-HT2C 和 5-HT3 受体，可减弱多巴胺释放。

GR 159897 is a competitive, brain-penetrated non-peptide NK2 receptor antagonist with anti-tumor effects. GR 159897 inhibits binding of [3H]GR100679 to human NK2-CHO cells and rat colon membranes (pKis: 9.51 and 10, respectively). It can antagonize bronch

GR148672X 是三酰甘油水解酶抑制剂(IC50:4 nM)。

GR-14-3-3 stabilizer-1 (compound 10) 是一种分子胶稳定剂，专门用于制备靶向糖皮质激素 (GR) 的分子胶，阻碍 GR 与 14-3-3 的相互作用。

GR-28 是小 C 端结构域磷酸酶 1 (SCP1) 的抑制剂。它能抑制阻遏元件 1 沉默转录因子 (REST) 的转录活性，并减少胶质母细胞瘤细胞的增殖，对细胞 A172 和 T98G 的 IC50 分别为 2.9 和 10.1 µM。

GR 125487 sulfamate is a 5-HT4 receptor antagonist.

5-HT1B/1D receptor antagonist

GR 144053 trihydrochloride是一种强效的选择性血小板 GPIIb/IIIa (integrin alphaIIb beta3) 受体拮抗剂 (IC50 = 20 nM)。它能显著抑制纤维蛋白原介导的血小板聚集，常用于血栓形成机制及抗血小板药物开发的研究。

GR 55562 dihydrochloride是一种选择性的血清素5-HT 1B拮抗剂，对5-HT 1D具有弱的拮抗作用，可用于研究神经系统疾病。

GR 89696 fumarate 是一种高效选择性的κ2 opioid receptor 受体激动剂(IC50 = 0.04 nM)，具有预防瘙痒、体内抗伤害和神经保护作用。

Potent and selective tachykinin NK2 receptor antagonist

GR 94800 acetate 是一种有效的选择性神经激肽 2(NK-2) 拮抗剂。

GR 122222X is an inhibitor of topoisomerase II.

GR-125487 is a 5-HT4R partial agonist. It also has favorable ADME properties and good in vivo efficacy.

GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder. GR-203040 is a selective NK1 receptor antagonist.

GR 100679 is an antagonist of NK2 receptor.

GR 83895 is an antagonist of prototype fibrinogen receptor.

GR 128107 is an antagonist of melatonin receptor.

GR 196429, a melatonin receptor agonist, exhibits selectivity for the MT1 subtype. This compound not only promotes sleep and alters circadian rhythms but also stimulates melatonin release in mice.